Difference between revisions of "PMID:6389761"
(Fill PMID: Page!) |
(→Notes) |
||
(4 intermediate revisions by the same user not shown) | |||
Line 51: | Line 51: | ||
|- | |- | ||
!|Phenotype of!!Taxon Information!!Genotype Information (if known)!!Condition Information!!OMP ID!!OMP Term Name!!ECO ID!!ECO Term Name!!Notes!!Status | !|Phenotype of!!Taxon Information!!Genotype Information (if known)!!Condition Information!!OMP ID!!OMP Term Name!!ECO ID!!ECO Term Name!!Notes!!Status | ||
+ | |- | ||
+ | | | ||
+ | a mutation or genetic difference within a strain | ||
+ | | | ||
+ | *Taxon: Escherichia coli | ||
+ | *Strain: K-12 | ||
+ | *Substrain: | ||
+ | *NCBI Taxon ID: [http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=83333&lvl=3&lin=f&keep=1&srchmode=1&unlock 83333] | ||
+ | | | ||
+ | *Genotype of Reference Strain: ''oppA'' | ||
+ | *Genotype of Experimental Strain : ''oppA'' | ||
+ | | | ||
+ | *Reference Condition: | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Resistance to alanyl-2-aminopropanoate. | ||
+ | | | ||
+ | |||
+ | |- | ||
+ | | | ||
+ | a mutation or genetic difference within a strain | ||
+ | | | ||
+ | *Taxon: Escherichia coli | ||
+ | *Strain: K-12 | ||
+ | *Substrain: | ||
+ | *NCBI Taxon ID: [http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=83333&lvl=3&lin=f&keep=1&srchmode=1&unlock 83333] | ||
+ | | | ||
+ | *Genotype of Reference Strain: ''dppA'' | ||
+ | *Genotype of Experimental Strain : ''dppA'' | ||
+ | | | ||
+ | *Reference Condition: | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Lysyl-2-aminooxypronate Resistance | ||
+ | | | ||
+ | |||
+ | |- | ||
+ | | | ||
+ | a mutation or genetic difference within a strain | ||
+ | | | ||
+ | *Taxon: Escherichia coli | ||
+ | *Strain: K-12 | ||
+ | *Substrain: | ||
+ | *NCBI Taxon ID: [http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=83333&lvl=3&lin=f&keep=1&srchmode=1&unlock 83333] | ||
+ | | | ||
+ | *Genotype of Reference Strain: ''tpp'' | ||
+ | *Genotype of Experimental Strain : ''tpp'' | ||
+ | | | ||
+ | *Reference Condition: | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Alafosfalin resistance | ||
+ | | | ||
+ | |||
|- class="tableEdit_footer" | |- class="tableEdit_footer" | ||
Line 58: | Line 133: | ||
==Notes== | ==Notes== | ||
+ | |||
+ | Needs OMP term, resistance to whatever this is and ECO term ID | ||
==References== | ==References== | ||
Line 64: | Line 141: | ||
− | [[Category:Publication]] | + | [[Category:Publication]] [[Category:LaRossa citations that need review]] [[Category:Papers referenced in the LaRossa chapter]] |
Latest revision as of 11:32, 1 May 2012
Citation |
Payne, JW, Morley, JS, Armitage, P and Payne, GM (1984) Transport and hydrolysis of antibacterial peptide analogues in Escherichia coli: backbone-modified aminoxy peptides.J. Gen. Microbiol. 130:2253-65 |
---|---|
Abstract |
Aminoxy analogues of di- and tripeptides in which the peptide linkage is replaced by -CO-NHO-, either as an L- or D-2-aminoxypropionic acid (L or D-OAla) residue, have been examined for antibacterial activity in vitro and for uptake into Escherichia coli. Isolation of analogue-resistant mutants and cross-resistance tests with peptide-transport mutants indicate that all three peptide permeases can transport these backbone-modified analogues. A number of mutants with defects in particular intracellular peptidases show decreased sensitivity to a range of these analogues, allowing identification of the enzymes responsible for their cleavage and confirming that hydrolysis is essential for their toxicity. Ala-OAla is a bacteriostatic agent that inhibits nucleic acid and protein synthesis within 1 min of being added to an exponentially growing culture. In crude extracts Ala-OAla inhibits transaminase activity but only after liberation of OAla by endogenous peptidases. These antibacterial agents illustrate an approach to drug targeting in which peptide carriers are used to promote uptake of essentially impermeant toxic moieties. |
Links | |
Keywords |
Alanine; Anti-Bacterial Agents; Biological Transport; Escherichia coli; Hydrolysis; Membrane Transport Proteins; Peptide Hydrolases; Peptides; Salmonella typhimurium |
edit table |
Main Points of the Paper
Please summarize the main points of the paper.
Materials and Methods Used
Please list the materials and methods used in this paper (strains, plasmids, antibodies, etc).
Phenotype Annotations
See Help:AnnotationTable for details on how to edit this table.
<protect>
Phenotype of | Taxon Information | Genotype Information (if known) | Condition Information | OMP ID | OMP Term Name | ECO ID | ECO Term Name | Notes | Status |
---|---|---|---|---|---|---|---|---|---|
a mutation or genetic difference within a strain |
|
|
|
Resistance to alanyl-2-aminopropanoate. |
|||||
a mutation or genetic difference within a strain |
|
|
|
Lysyl-2-aminooxypronate Resistance |
|||||
a mutation or genetic difference within a strain |
|
|
|
Alafosfalin resistance |
| ||||
edit table |
</protect>
Notes
Needs OMP term, resistance to whatever this is and ECO term ID
References
See Help:References for how to manage references in omp dev.